# Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome.

> PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30470553-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-06-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30470553-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30470553-linaclotide-v1.json
- Content SHA-256: `217aeac8647a98ec7727ccfa8aafbf488e85bf8d74b37a3aa9701af9bdb285b0`

## Claims and source pins

### Headline

Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

### Summary

PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

### Paragraph 1

PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

## Sources

<a id="source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160"></a>
- **Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome. · retained source version 1:2019-06-13:current:14e2cd939160719beb7a660d9f0c77e181cca2acc1b15db047be2e1ffef96943** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30470553/) (`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30470553-linaclotide-v1.json SHA-256: 217aeac8647a98ec7727ccfa8aafbf488e85bf8d74b37a3aa9701af9bdb285b0.